MedTrace Logo

Evaluation of the Effect of Venous Diameter Measurement by Ultrasonography on Pain and Withdrawal Response

NCT03376308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2017-12-19

No results posted yet for this study

Summary

During general anesthesia, intravenous (IV) medications can disrupt the patient's comfort by causing a pain sensation or a withdrawal response in the heart. Propofol and rocuronium are among the most common causes of this condition.

In recent years, the use of ultrasonography (USG) in anesthesia has become widespread with the rapid advancement of technology. The use of the patient's head is a non invasive method.

This study is aimed to evaluate whether the size of the venous diameter assessed by ultrasonography in our study is an effect on pain and withdrawal response after drug injections.

Conditions

Interventions

DIAGNOSTIC_TEST

Pain Score

Four poin scala 0=No Pain 1. mild 2. intermediate 3. severe

DIAGNOSTIC_TEST

Withdrawal movement score

Withdrawal movements 1. no movement response 2. movement limited to the wrist 3. movement limited to the elbow/shoulder, 4. generalized movement response.

DIAGNOSTIC_TEST

hemodynamic response

Hemodynamic data were recorded in the patients taken in the operation room. (T0). Hemodynamic values (T1) measured 1 minute after administration of intravenous propofol were recorded. Hemodynamic values (T2) measured 1 minute after administration of intravenous rocuronium were recorded. Hemodynamic values (T3) measured 1 minute after administration of endotracheal intubation were recorded.

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Principal Investigators

  • Sinan Yılmaz · Aydin Adnan Menderes University

Eligibility

Min Age
17 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2017-10-01
Completion
2017-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03376308 on ClinicalTrials.gov